HIF1A and hepatocellular carcinoma: In each of two cell lines studied, Hep3B (derived from human hepatoma cells) and HEK293T (derived from human embryonic kidney cells), substantially more PTPRZ1 promoter activity, as assessed using a luciferase reporter assay, was observed in response to HIF-2α as compared to HIF-1α.